Nitric Oxide and Cancer: An Overview

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1007/978-1-4419-1432-3_1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Constitutive intracellular production of iNOS and NO in human melanoma: possible role in regulation of growth and resistance to apoptosis.

  2008cited by this paper
• Nitric oxide is a key component in inflammation-accelerated tumorigenesis.

  2008cited by this paper
• Neuronal nitric oxide synthase expression in glial tumors: correlation with malignancy and tumor proliferation

  2008cited by this paper
• Molecular mechanisms for discrete nitric oxide levels in cancer.

  2008cited by this paper
• The chemical biology of nitric oxide: implications in cellular signaling.

  2008cited by this paper
• Prognostic significance of iNOS in epithelial ovarian cancer.

  2007cited by this paper
• Nitric oxide promotes airway epithelial wound repair through enhanced activation of MMP-9.

  2007cited by this paper
• Inflammation and cancer: An ancient link with novel potentials

  2007cited by this paper
• Inducible nitric oxide synthase expression in various laryngeal lesions in relation to carcinogenesis, angiogenesis, and patients’ prognosis

  2007cited by this paper
• Genetic polymorphisms of NOS3 are associated with the risk of invasive breast cancer with lymph node involvement

  2007cited by this paper
• Nitric Oxide and Its Gatekeeper Thrombospondin-1 in Tumor Angiogenesis

  2007cited by this paper
• Regulation of HIF-1α Stability through S-nitrosylation

  2007cited by this paper
• Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways

  2007cited by this paper
• Inflammation and IGF‐I activate the Akt pathway in breast cancer

  2007cited by this paper
• Nitric oxide induces CD4+CD25+ Foxp3− regulatory T cells from CD4+CD25− T cells via p53, IL-2, and OX40

  2007cited by this paper
• TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer

  2007cited by this paper
• Inactivation of nitric oxide by rat cerebellar slices

  2006cited by this paper
• The Biphasic Nature of Nitric Oxide Responses in Tumor Biology

  2006cited by this paper
• Chronic lymphocytic leukemia cell CD38 expression and inducible nitric oxide synthase expression are associated with serum IL-4 levels.

  2006cited by this paper
• Tumor iNOS predicts poor survival for stage III melanoma patients

  2006cited by this paper
• Expression of inducible nitric oxide synthase and cyclooxygenase‐2 in angiogenesis and clinical outcome of human gastric cancer

  2006cited by this paper
• Superoxide Fluxes Limit Nitric Oxide-induced Signaling*

  2006cited by this paper
• Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma.

  2006cited by this paper
• Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: an immunohistochemical study of 151 cases

  2005cited by this paper
• Inducible nitric oxide synthase, nitrotyrosine and apoptosis in gastric adenocarcinomas and their correlation with a poor survival.

  2005cited by this paper
• Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1.

  2005cited by this paper
• Expressions of inducible nitric oxide synthase and matrix metalloproteinase-9 and their effects on angiogenesis and progression of hepatocellular carcinoma.

  2005cited by this paper
• Expression of endothelial nitric oxide synthase correlates with the angiogenic phenotype of and predicts poor prognosis in human gastric cancer

  2005cited by this paper
• Is the hypoxia-inducible factor pathway important in gastric cancer?

  2005cited by this paper
• Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy.

  2005cited by this paper
• NO news is not necessarily good news in cancer.

  2005cited by this paper
• Hypoxic inducible factor 1α, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide

  2004cited by this paper
• Real time and in vivo monitoring of nitric oxide by electrochemical sensors--from dream to reality.

  2004cited by this paper
• Induction of apoptosis in colorectal carcinoma cells treated with 4-hydroxy-2-nonenal and structurally related aldehydic products of lipid peroxidation.

  2004cited by this paper
• Malondialdehyde adducts in DNA arrest transcription by T7 RNA polymerase and mammalian RNA polymerase II.

  2004cited by this paper
• A novel genetic polymorphism of inducible nitric oxide synthase is associated with an increased risk of gastric cancer.

  2004cited by this paper
• Oligonucleotide directed mutagenesis: Selection of mutants by hemimethylation of GATC-sequences

  2004cited by this paper
• Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations.

  2004cited by this paper
• Nitric oxide and p53 in cancer‐prone chronic inflammation and oxyradical overload disease

  2004cited by this paper
• Thresholds of nitric oxide-mediated toxicity in human lymphoblastoid cells.

  2003cited by this paper
• Macrophage Endothelial Nitric-oxide Synthase Autoregulates Cellular Activation and Pro-inflammatory Protein Expression*

  2003cited by this paper
• Inhibition of poly(ADP-RIBOSE) polymerase (PARP) by nitric oxide and reactive nitrogen oxide species.

  2003cited by this paper
• MKP-1-induced dephosphorylation of extracellular signal-regulated kinase is essential for triggering nitric oxide-induced apoptosis in human breast cancer cell lines: implications in breast cancer.

  2003cited by this paper
• High expression of nitric oxide synthases is a favorable prognostic sign in non‐small cell lung carcinoma

  2003cited by this paper
• Role of nitric oxide in tumour progression with special reference to a murine breast cancer model.

  2002cited by this paper
• Nitric oxide-induced cellular stress and p53 activation in chronic inflammation

  2002cited by this paper
• Association between Inducible Nitric Oxide Synthase Expression and p53 Status in Human Esophageal Squamous Cell Carcinoma

  2002cited by this paper
• Cyclooxygenase-2: a therapeutic target.

  2002cited by this paper
• Nitric oxide and wound repair: role of cytokines?

  2002cited by this paper
• Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer.

  2001cited by this paper
• Comparison of control of Listeria by nitric oxide redox chemistry from murine macrophages and NO donors: insights into listeriocidal activity of oxidative and nitrosative stress.

  2001cited by this paper
• Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.

  2001cited by this paper
• Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology and human risk assessment.

  2001cited by this paper
• Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors

  2001cited by this paper
• Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice

  2001cited by this paper
• Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival.

  2000cited by this paper
• Nitrosative Capacity of Macrophages Is Dependent on Nitric-oxide Synthase Induction Signals*

  2000cited by this paper
• Regulation of transforming growth factor b1 by nitric oxide

  1999cited by this paper
• Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer.

  1999cited by this paper
• Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer.

  1998cited by this paper
• Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice.

  1998cited by this paper
• Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide.

  1998cited by this paper
• Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression.

  1998cited by this paper
• A discussion of mechanisms of NO genotoxicity: implication of inhibition of DNA repair proteins.

  1997cited by this paper
• Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck.

  1997cited by this paper
• Activation of nitric oxide synthase gene for inhibition of cancer metastasis

  1996cited by this paper
• Kinetic modelling of the nitric oxide gradient generated in vitro by adherent cells expressing inducible nitric oxide synthase.

  1996cited by this paper
• Nitric oxide inhibits DNA ligase activity: potential mechanisms for NO-mediated DNA damage.

  1996cited by this paper
• Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53.

  1996cited by this paper
• Chemical biology of nitric oxide: regulation and protective and toxic mechanisms.

  1996cited by this paper
• Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells

  1995cited by this paper
• Nitric oxide and ethylnitrosourea: relative mutagenicity in the p53 tumor suppressor and hypoxanthine-phosphoribosyltransferase genes.

  1995cited by this paper
• The causes and prevention of cancer.

  1995cited by this paper
• Nitric oxide synthase activity in human breast cancer.

  1995cited by this paper
• Roles of nitric oxide in tumor growth.

  1995cited by this paper
• The Fpg protein, a DNA repair enzyme, is inhibited by the biomediator nitric oxide in vitro and in vivo.

  1994cited by this paper
• Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation.

  1994cited by this paper
• Nitrite-induced mutations in a forward mutation assay: influence of nitrite concentration and pH.

  1994cited by this paper
• DNA sequence changes induced by two nitric oxide donor drugs in the supF assay.

  1994cited by this paper
• Inhibition by nitric oxide of the repair protein, O6-DNA-methyltransferase

  1994cited by this paper
• Nitric oxide synthase activity in human gynecological cancer.

  1994cited by this paper
• Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species.

  1993cited by this paper
• Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium.

  1993cited by this paper
• Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin‐6 by rat Kupffer cells

  1993cited by this paper
• Mutations induced by saturated aqueous nitric oxide in the pSP189 supF gene in human Ad293 and E. coli MBM7070 cells.

  1993cited by this paper
• DNA damage and mutation in human cells exposed to nitric oxide in vitro.

  1992cited by this paper
• Nitrite and nitrosamine synthesis by hepatocytes isolated from normal woodchucks (Marmota monax) and woodchucks chronically infected with woodchuck hepatitis virus.

  1992cited by this paper
• Genetic effects of oxidative DNA damage: comparative mutagenesis of 7,8-dihydro-8-oxoguanine and 7,8-dihydro-8-oxoadenine in Escherichia coli.

  1992cited by this paper
• Nitric oxide: an endogenous modulator of leukocyte adhesion.

  1991cited by this paper
• Elevated formation of nitrate and N-nitrosodimethylamine in woodchucks (Marmota monax) associated with chronic woodchuck hepatitis virus infection.

  1991cited by this paper
• DNA deaminating ability and genotoxicity of nitric oxide and its progenitors.

  1991cited by this paper
• Nitric oxide: physiology, pathophysiology, and pharmacology.

  1991cited by this paper
• L-arginine-dependent formation of N-nitrosamines by the cytosol of macrophages activated with lipopolysaccharide and interferon-gamma.

  1991cited by this paper
• EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages.

  1990cited by this paper
• Solid tumours and wounds: transformed cells misunderstood as injured tissue?

  1990cited by this paper
• Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells

  1989cited by this paper
• Nitric oxide: a cytotoxic activated macrophage effector molecule.

  1988cited by this paper
• Mammalian synthesis of nitrite, nitrate, nitric oxide, and N-nitrosating agents.

  1988cited by this paper
• Mutagenesis by the autoxidation of iron with isolated DNA.

  1988cited by this paper
• L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells.

  1987cited by this paper

• Macrophage Reprogramming and Cancer Therapeutics: Role of iNOS-Derived NO

  2021cites this paper
• Tumor associated macrophages and 'NO'.

  2020cites this paper
• Nitric Oxide and Cancer: To Inhibit or To Induce iNOS: That Is the Question?

  2019cites this paper
• The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.

  2018cites this paper
• Molecular Hybridization Tools in the Development of Furoxan‐Based NO‐Donor Prodrugs

  2017cites this paper
• In Vitro Evaluation of Hepg2 Cell Proliferation Altered by Reactive Oxygen and Nitrogen Species

  2016cites this paper
• Kinetics and thermodynamics of reversible disproportionation–comproportionation in redox triad oxoammonium cations – nitroxyl radicals – hydroxylamines

  2015cites this paper
• Optimization of methyl jasmonate application to broccoli florets to enhance health-promoting phytochemical content.

  2014cites this paper
• Preliminary evaluation of the interactions of Panax ginseng and Salvia miltiorrhiza Bunge with 5-fluorouracil on pharmacokinetics in rats and pharmacodynamics in human cells.

  2013cites this paper
• β-galactosyl-pyrrolidinyl diazeniumdiolate: an efficient tool to investigate nitric oxide functions on promoting cell death

  2013cites this paper
• Nitric oxide and protein phosphatase 2 A provide novel therapeutic opportunities in ER-negative breast cancer

  2012influential citation
• S-Nitrosylation of EGFR and Src Activates an Oncogenic Signaling Network in Human Basal-Like Breast Cancer

  2012cites this paper
• Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer

  2012cites this paper
• Signaling and Regulation S-Nitrosylation of EGFR and Src Activates an Oncogenic Signaling Network in Human Basal-Like Breast Cancer

  2012cites this paper
• S-Nitrosation Mediates Multiple Pathways That Lead to Tumor Progression in Estrogen Receptor-Negative Breast Cancer.

  2012cites this paper
• Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer.

  2011cites this paper